American National Insurance’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
American National Insurance's BMY Position: Q1 2022 in Review
American National Insurance reduced its Bristol-Myers Squibb (BMY) stake by 19% in Q1 2022, selling an estimated $144K and leaving 9,450 shares worth $690K. The position accounts for 0.19% of the portfolio, ranked #159.
American National Insurance first reported a position in BMY in Q4 2019 and has held it in 10 quarters since. The position peaked at $5.36M in Q2 2021. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- American National Insurance held 9,450 shares of Bristol-Myers Squibb worth $690K as of Q1 2022.
- American National Insurance sold 2,150 Bristol-Myers Squibb shares in Q1 2022, an estimated $144K.
- Bristol-Myers Squibb made up 0.19% of American National Insurance's portfolio in Q1 2022, its #159 holding.
- American National Insurance first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 10 quarters since.
- American National Insurance's Bristol-Myers Squibb position peaked at $5.36M in Q2 2021.
- 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.